XBiotech Inc. — Director's Dealing 2020

Jan 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2020-01-06

Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-06	Common Stock	M	123000	$3.75	Acquired	3706600	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-06	Stock Option	$3.75	M	77000	Disposed	2020-01-25	Common Stock (77000)	Direct
2020-01-06	Stock Option	$3.75	M	46000	Disposed	2020-02-01	Common Stock (46000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11501	Indirect
Common Stock	100000	Indirect
Common Stock	47738	Indirect